Dashboard
Manage Tickers

IBMINTERNATIONAL BUSINESS MACH...

NYSE ibm.com


$ 174.16 $ 4.24 (2.5 %)    

Tuesday, 21-May-2024 11:31:02 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 454.82 $ 0.51 (0.11 %)
DIA $ 398.57 $ 0.35 (0.09 %)
SPY $ 530.36 $ 1.11 (0.21 %)
TLT $ 91.26 $ -0.23 (-0.25 %)
GLD $ 225.37 $ 0.05 (0.02 %)
$ 169.92
$ 169.98
$ 174.07 x 100
$ 180.00 x 133
$ 169.98 - $ 174.90
$ 119.91 - $ 197.22
2,726,261
na
158.61B
$ 0.83
$ 19.39
TBD
na
na ($ 0.04)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-30-2024 03-31-2024 10-Q
2 02-26-2024 12-31-2023 10-K
3 10-31-2023 09-30-2023 10-Q
4 07-25-2023 06-30-2023 10-Q
5 04-25-2023 03-31-2023 10-Q
6 02-28-2023 12-31-2022 10-K
7 10-25-2022 09-30-2022 10-Q
8 07-25-2022 06-30-2022 10-Q
9 04-26-2022 03-31-2022 10-Q
10 02-22-2022 12-31-2021 10-K
11 11-05-2021 09-30-2021 10-Q
12 07-27-2021 06-30-2021 10-Q
13 04-27-2021 03-31-2021 10-Q
14 02-23-2021 12-31-2020 10-K
15 10-27-2020 09-30-2020 10-Q
16 07-28-2020 06-30-2020 10-Q
17 04-28-2020 03-31-2020 10-Q
18 02-25-2020 12-31-2019 10-K
19 10-30-2019 09-30-2019 10-Q
20 07-30-2019 06-30-2019 10-Q
21 04-30-2019 03-31-2019 10-Q
22 02-26-2019 12-31-2018 10-K
23 10-30-2018 09-30-2018 10-Q
24 07-31-2018 06-30-2018 10-Q
25 04-24-2018 03-31-2018 10-Q
26 02-27-2018 12-31-2017 10-K
27 10-31-2017 09-30-2017 10-Q
28 07-25-2017 06-30-2017 10-Q
29 04-25-2017 03-31-2017 10-Q
30 02-28-2017 12-31-2016 10-K
31 10-25-2016 09-30-2016 10-Q
32 07-26-2016 06-30-2016 10-Q
33 04-26-2016 03-31-2016 10-Q
34 02-23-2016 12-31-2015 10-K
35 10-27-2015 09-30-2015 10-Q
36 07-28-2015 06-30-2015 10-Q
37 04-28-2015 03-31-2015 10-Q
38 02-24-2015 12-31-2014 10-K
39 10-28-2014 09-30-2014 10-Q
40 07-29-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

whats-going-on-with-ibm-shares-on-tuesday
What's Going On With IBM Shares On Tuesday?
05/21/2024 13:30:56

IBM explores integrating IBM Granite models with Salesforce's Einstein 1 platform while partnering with AWS to enhance AI g...

palo-altos-conservative-approach-fails-to-impress
Palo Alto's Conservative Approach Fails To...
05/21/2024 13:09:03

On Monday, Palo Alto Networks (NASDAQ: PANW) shares plunged upon its fiscal third quarter report that failed to impress due to ...

Core News & Articles
IBM And Salesforce Expand Partnership To A...
05/21/2024 10:06:34

ibm-expands-watsonx-portfolio-on-aws-adds-watsonxgovernance-to-help-clients-scale-responsible-ai
IBM Expands watsonx Portfolio On AWS, Adds...
05/21/2024 10:01:35

ibm-ventures-into-open-source-ai-with-granite-models-strikes-training-deal-with-saudi-arabia-for-arabic-ai-system
IBM Ventures Into Open-Source AI With 'Gra...
05/21/2024 08:47:50

IBM has announced that it will be releasing a new set of artificial intelligence models as open-source software. Additionally, ...

ibm-introduces-new-developments-in-watsonx-with-open-source-product-and-ecosystem-innovations-to-scale-enterprise-ai
IBM Introduces New Developments In watsonx...
05/21/2024 05:02:05

Releases a family of IBM Granite models into open source, including its most capable and efficient Code LLMs that can out-per...

reddits-inclusion-of-chatgpt-triggers-ibm-watson-fiasco-dj-vu-a-recipe-for-disaster
Reddit's Inclusion Of ChatGPT Triggers IBM...
05/17/2024 15:37:42

Reddit user expresses concern over the potential for an "AI brain explosion" as OpenAI crawls through "soooo much s...

snowflake-analysts-remain-overweight-potential-growth-despite-iceberg-adoption-concerns
Snowflake Analysts Remain Overweight: Pote...
05/16/2024 17:47:29

Piper Sandler analyst attended Virtual Iceberg Summit with tech giants. Snowflake seen as having potential drag on growth, but ...

stifel-maintains-buy-on-ibm-maintains-190-price-target
Stifel Maintains Buy on IBM, Maintains $19...
05/16/2024 17:47:22

Stifel analyst David Grossman maintains IBM (NYSE:IBM) with a Buy and maintains $190 price target.

rbc-capital-reiterates-outperform-on-ibm-maintains-200-price-target
RBC Capital Reiterates Outperform on IBM, ...
05/16/2024 16:34:45

RBC Capital analyst Matthew Swanson reiterates IBM (NYSE:IBM) with a Outperform and maintains $200 price target.

palo-alto-networks-stock-is-getting-a-lift-from-ibm-thursday-whats-going-on
Palo Alto Networks Stock Is Getting A Lift...
05/16/2024 13:20:33

Palo Alto and IBM announced the broad-reaching partnership that aims to help address increasingly sophisticated threats and evo...

Core News & Articles
Palo Alto Networks, IBM Announce Broad-Rea...
05/15/2024 20:33:33

As part of this expanded partnership, Palo Alto Networks has agreed to acquire IBM's QRadar SaaS assets, including QRadar i...

behind-the-scenes-of-ibms-latest-options-trends
Behind the Scenes of IBM's Latest Options ...
05/15/2024 18:16:51

wall-streets-most-accurate-analysts-say-hold-these-3-tech-stocks-delivering-high-dividend-yields
Wall Street's Most Accurate Analysts Say H...
05/14/2024 12:30:54

Core News & Articles
Schumer's long-awaited AI 'road map' is co...
05/13/2024 20:40:05

https://www.washingtonpost.com/technology/2024/05/13/congress-ai-laws-research-regulation-schumer/

Core News & Articles
OpenAI CTO Announces GPT-4o Model To Be Fr...
05/13/2024 17:09:43

Core News & Articles
TD SYNNEX Launches IBM watsonx Gold 100 Pr...
05/13/2024 13:05:55

from-hype-to-reality-ai-reshapes-pharmaceutical-industry-across-drug-discovery-to-marketing---stocks-to-watch
From Hype To Reality, AI Reshapes Pharmace...
05/10/2024 18:49:35

Unlock the potential of AI in pharmaceuticals. With AI's help, the pharma industry could see $60B-$110B in annual economic ...

Core News & Articles
IBM Unveils New Microsoft Copilot Capabili...
05/09/2024 12:27:38

ibm-options-trading-a-deep-dive-into-market-sentiment
IBM Options Trading: A Deep Dive into Mark...
05/08/2024 17:15:42

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION